Bullish Case: Despite flat trade since Mar, BFLY is still $7.665 (> $6), partially matching my steady-growth bullish view. The BFLY IV surface is backwardated: near-term IV concentrates on low strikes/puts more than the ~$7.5–$10 band, implying chop risk. BFLY return-density shows the highest likelihood ridge around +36% to +145% vs deep negatives. SPY IV looks contained (~10–20). With HeliumTrades AI forecast 0% (corr -0.1), edge is modest.

Bearish Case: BFLY downside tail risk remains priced: the BFLY IV surface shows elevated IV at low strikes and strong put premiums, consistent with my March left-tail warning. Backwardation raises event-driven gap risk into Jul17/Aug21. The return surface includes non-negligible negative outcomes down to -74%, while the wider right tail (+900%) is thin. If next catalysts miss (cash burn/regulatory), a move into $4–$5 is plausible, and butterfly-like structures centered near $7.5 could face gamma/IV risk.

Potential Outcomes:

1. 25% GovRAMP/AI ≥$10M bookings (by Aug21) ⇒ $10–$12.
2. 30% In-line run-rate; BFLY $6–$9; realized vol < IV ⇒ butterfly works.
3. 15% Guidance/cash-burn trim (Jul17) ⇒ <$5.
4. 10% Reg/clinical miss ⇒ -20% day (low-strike IV would validate).
5. 12% Macro risk-off; SPY IV >20 or -3% week ⇒ $4–$6.
6. 8% Call-driven squeeze + vol compression ⇒ $12+.

June 24, 2026